VYNE Therapeutics
VYNE
VYNE
89 hedge funds and large institutions have $154M invested in VYNE Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 24 increasing their positions, 26 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
8% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 26
14% less funds holding
Funds holding: 104 → 89 (-15)
44% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 32
Holders
89
Holding in Top 10
2
Calls
$845K
Puts
$164K
Top Buyers
| 1 | +$7.22M | |
| 2 | +$4.17M | |
| 3 | +$4.13M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.42M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$1.25M |
Top Sellers
| 1 | -$9.43M | |
| 2 | -$1.28M | |
| 3 | -$809K | |
| 4 |
Renaissance Technologies
New York
|
-$725K |
| 5 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
-$685K |